JP2002348254A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002348254A5 JP2002348254A5 JP2001155237A JP2001155237A JP2002348254A5 JP 2002348254 A5 JP2002348254 A5 JP 2002348254A5 JP 2001155237 A JP2001155237 A JP 2001155237A JP 2001155237 A JP2001155237 A JP 2001155237A JP 2002348254 A5 JP2002348254 A5 JP 2002348254A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- acid sequence
- amino acid
- nervous system
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 206010061311 nervous system neoplasm Diseases 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001155237A JP2002348254A (ja) | 2001-05-24 | 2001-05-24 | 神経系腫瘍治療剤 |
| US10/478,514 US20040147438A1 (en) | 2001-05-24 | 2001-10-03 | Remedies for nervous tumor |
| PCT/JP2001/008701 WO2002094306A1 (fr) | 2001-05-24 | 2001-10-03 | Remedes pour le traitement des tumeurs nerveuses |
| CA002446510A CA2446510A1 (en) | 2001-05-24 | 2001-10-03 | Therapeutic agent for tumor of neural origin |
| US11/771,083 US20070299031A1 (en) | 2001-05-24 | 2007-06-29 | Therapeutic agent for tumor of neural origin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001155237A JP2002348254A (ja) | 2001-05-24 | 2001-05-24 | 神経系腫瘍治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002348254A JP2002348254A (ja) | 2002-12-04 |
| JP2002348254A5 true JP2002348254A5 (enExample) | 2005-09-08 |
Family
ID=18999466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001155237A Pending JP2002348254A (ja) | 2001-05-24 | 2001-05-24 | 神経系腫瘍治療剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20040147438A1 (enExample) |
| JP (1) | JP2002348254A (enExample) |
| CA (1) | CA2446510A1 (enExample) |
| WO (1) | WO2002094306A1 (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2427858A1 (en) * | 2000-11-03 | 2002-05-10 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
| KR20060031809A (ko) * | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
-
2001
- 2001-05-24 JP JP2001155237A patent/JP2002348254A/ja active Pending
- 2001-10-03 CA CA002446510A patent/CA2446510A1/en not_active Abandoned
- 2001-10-03 US US10/478,514 patent/US20040147438A1/en not_active Abandoned
- 2001-10-03 WO PCT/JP2001/008701 patent/WO2002094306A1/ja not_active Ceased
-
2007
- 2007-06-29 US US11/771,083 patent/US20070299031A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005537234A5 (enExample) | ||
| AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
| EP1832599A3 (en) | Albumin fusion proteins | |
| WO2003060071A3 (en) | Albumin fusion proteins | |
| BRPI0511118A (pt) | polipeptìdeos de haemophilus influenzae não transcritos | |
| CA2257133A1 (en) | Human dnase i hyperactive variants | |
| JP2005527470A5 (enExample) | ||
| WO2003059934A3 (en) | Albumin fusion proteins | |
| WO2005040418A3 (en) | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt | |
| YU68702A (sh) | Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka | |
| DE60037978D1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
| WO2001068676A3 (de) | Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel | |
| WO2004085461A3 (de) | An mhc-moleküle bindende tumor-assoziierte peptide | |
| JP2002348254A5 (enExample) | ||
| DE69924877D1 (en) | Humanes akt-3 protein | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| WO2001057069A3 (en) | Targeting peptides | |
| CA2290739A1 (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers | |
| ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| JP2007517775A5 (enExample) | ||
| JP2002335964A5 (enExample) | ||
| JP2004196700A5 (enExample) | ||
| WO2002000826A3 (fr) | Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide | |
| JP2002335976A5 (enExample) |